½ÃÀ庸°í¼­
»óǰÄÚµå
1572446

Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå : ±âȸ, ¼ºÀå µ¿ÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2024-2032³â)

Medication Management Systems Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 160 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº ÀÇ·á ±â¼ú ¹ßÀü, °í·É Àα¸ Áõ°¡, ¸¸¼º Áúȯ À¯º´·ü Áõ°¡ µîÀ» ¹è°æÀ¸·Î 2024³âºÎÅÍ 2032³â±îÁö 9.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

¶ÇÇÑ, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°ú ÀüÀÚ Ã³¹æÀü µµÀÔÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ ÀÌ·¯ÇÑ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

´ç´¢º´À̳ª °íÇ÷¾Ð°ú °°Àº ¸¸¼ºÁúȯÀÌ È®»êµÊ¿¡ µû¶ó Àå±âÀûÀÎ ¾à¼ö󸮿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀüÀÚó¹æ(e-prescribing)°ú ÀüÀÚÀǹ«±â·Ï(EHR)Àº ¾à¹° °ü¸® ½Ã½ºÅÛ »ê¾÷À» À̲ô´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ¾à¹° Á¤º¸ÀÇ ¿øÈ°ÇÑ ÅëÇÕÀ» º¸ÀåÇϰí ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü, ¾à±¹ ¹× ȯÀÚ °£ÀÇ ÀÇ»ç ¼ÒÅëÀ» °­È­ÇÏ¿© Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ ¾à¹° °ü¸®¸¦ º¸ÀåÇÕ´Ï´Ù.

¾à¹° °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº ¼ÒÇÁÆ®¿þ¾î À¯Çü, ¹èÆ÷ ¸ðµå, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªº°·Î ºÐ·ùµË´Ï´Ù.

ÀÌ ½ÃÀåÀº ¼ÒÇÁÆ®¿þ¾î À¯ÇüÀ» ÀÓ»ó ÀÇ»ç°áÁ¤ Áö¿ø ½Ã½ºÅÛ ¼Ö·ç¼Ç(CDSS), Àç°í °ü¸® ¹× °ø±Þ¸Á °ü¸® ¼ÒÇÁÆ®¿þ¾î, ÀÇ»ç ÄÄÇ»ÅÍ ÁÖ¹® ÀÔ·Â(CPOE), Àüȯ Åõ¾à °ü¸®, °ü¸® ¼ÒÇÁÆ®¿þ¾î, º¸Áõ ½Ã½ºÅÛ ¼ÒÇÁÆ®¿þ¾î, ±âŸ ¼ÒÇÁÆ®¿þ¾î·Î ºÐ·ùÇÕ´Ï´Ù. 2023³â CDSS(Clinical Decision Support System Solutions) ºÎ¹®ÀÌ 11¾ï ´Þ·¯ÀÇ ¸ÅÃâÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CDSS ¼Ö·ç¼ÇÀº ÀÇ·áÁø¿¡°Ô ½Ç½Ã°£À¸·Î ±Ù°Å¿¡ ±â¹ÝÇÑ ÁöħÀ» Á¦°øÇÔÀ¸·Î½á ¾à¹° ¿À³²¿ëÀ» ÁÙÀÌ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ÀÇ·áÁø¿¡°Ô ½Ç½Ã°£À¸·Î ±Ù°Å ±â¹Ý °¡À̵带 Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ÀáÀçÀûÀÎ ¾à¹° »óÈ£ ÀÛ¿ë, ¾Ë·¹¸£±â, ±Ý±â »çÇ×À» ÀÇ·áÁø¿¡°Ô ¾Ë·ÁÁÖ¾î À¯ÇØÇÑ ½Ç¼ö¸¦ ¹æÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á°è°¡ ¾à¹° ¿À³²¿ë¿¡ ´ëÇÑ ¿ì·Á°¡ Áö¼ÓµÇ°í ÀÖ´Ù´Â Á¡À» °¨¾ÈÇÒ ¶§, ¾à¹° °ü¸®¿¡¼­ CDSSÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ±× Á߿伺ÀÌ Ä¿Áö°í ÀÖÀ½À» ÀÔÁõÇÕ´Ï´Ù.

¾à¹° °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº ¹èÆ÷ ¸ðµå¸¦ Ŭ¶ó¿ìµå ±â¹Ý, ¿ÂÇÁ·¹¹Ì½º, À¥ ±â¹Ý ¼Ö·ç¼ÇÀ¸·Î ºÐ·ùÇϰí ÀÖÀ¸¸ç, 2023³â¿¡´Â Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®ÀÌ 48%ÀÇ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¾à¹° °ü¸® ½Ã½ºÅÛÀº Ź¿ùÇÑ È®À强À» Á¦°øÇÕ´Ï´Ù. µû¶ó¼­ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ¼Ò±Ô¸ð Ŭ¸®´ÐºÎÅÍ ´ë±Ô¸ð º´¿ø ³×Æ®¿öÅ©¿¡ À̸£±â±îÁö ´ë±Ô¸ð ÀÎÇÁ¶ó ÅõÀÚ ¾øÀ̵µ ¼ö¿ä¿¡ µû¶ó ¼­ºñ½º¸¦ Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀûÀÀ¼ºÀÌ Å¬¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç µµÀÔÀÌ ±ÞÁõÇÏ´Â ÁÖ¿ä ÀÌÀ¯ÀÔ´Ï´Ù.

¶ÇÇÑ, Ŭ¶ó¿ìµå ±â¹Ý ½Ã½ºÅÛÀº ºñ¿ëÀÌ ¸¹ÀÌ µå´Â ¿ÂÇÁ·¹¹Ì½º Çϵå¿þ¾î, À¯Áöº¸¼ö ¹× IT Áö¿øÀÌ ÇÊ¿äÇÏÁö ¾Ê±â ¶§¹®¿¡ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô´Â »ó´çÇÑ ºñ¿ë Àý°¨ È¿°ú¸¦ °¡Á®´ÙÁÝ´Ï´Ù. Á¶Á÷Àº ¹°¸®Àû ¼­¹ö³ª ¼ÒÇÁÆ®¿þ¾î ¶óÀ̼±½º¿¡ ÅõÀÚÇÏ´Â ´ë½Å »ç¿ëÇÑ ¼­ºñ½º¿¡ ´ëÇØ¼­¸¸ ºñ¿ëÀ» ÁöºÒÇÏ´Â ±¸µ¶ ±â¹Ý ¸ðµ¨·Î ÀüȯÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °æÁ¦Àû ÀÌÁ¡Àº ƯÈ÷ ¼Ò±Ô¸ð ÀÇ·á ±â°üÀ̳ª ¿¹»êÀÌ ÇÑÁ¤µÈ ÀÇ·á ±â°ü¿¡°Ô ¸Å·ÂÀûÀ̸ç, ÀÌ ºÎ¹® ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

2023³â ºÏ¹Ì Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº 17¾ï ´Þ·¯ ±Ô¸ð·Î 2024³âºÎÅÍ 2032³â±îÁö 9.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºÏ¹Ì, ƯÈ÷ ¹Ì±¹Àº ¼¼°è¿¡¼­ °¡Àå Á¤±³ÇÑ ÀÇ·á ÀÎÇÁ¶ó¸¦ º¸À¯Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ½Ã¼³°ú ¾à¹° °ü¸® ½Ã½ºÅÛ°ú °°Àº Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÇ Á¶±â µµÀÔ Ãß¼¼°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡´Â ¸¸¼º ÁúȯÀÌ ¸¹°í º¹ÀâÇÑ Åõ¾à °èȹÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ º¹¾à ¼øÀÀµµ¸¦ º¸ÀåÇϰí Åõ¾à ¿À·ù¸¦ ÃÖ¼ÒÈ­Çϱâ À§ÇÑ ½Ã½ºÅÛÀÇ Á߿伺ÀÌ ´õ¿í °­Á¶µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©£¦°úÁ¦
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ±â¼ú µ¿Çâ
  • ÁÖ¿ä ½ÃÀå µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • °¸ ºÐ¼®
  • ÇâÈÄ ½ÃÀå µ¿Çâ

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ - °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¼ÒÇÁÆ®¿þ¾î À¯Çüº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ÀÓ»ó ÀÇ»ç°áÁ¤ Áö¿ø ½Ã½ºÅÛ ¼Ö·ç¼Ç(CDSS)
  • Àç°í °ü¸® ¹× °ø±Þ¸Á °ü¸® ¼ÒÇÁÆ®¿þ¾î
  • ÄÄÇ»ÅÍ ÀÇ»ç ¿À´õ ¿£Æ®¸® ¼ÒÇÁÆ®¿þ¾î(CPOE)
  • Àü¿ë¾à°ü¸®
  • °ü¸® ¼ÒÇÁÆ®¿þ¾î
    • ¹ÙÄÚµå Åõ¾à ±â·Ï
    • ÀüÀÚ Åõ¾à ±â·Ï
  • º¸Áõ ½Ã½ºÅÛ ¼ÒÇÁÆ®¿þ¾î
  • ±âŸ ¼ÒÇÁÆ®¿þ¾î

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Àü°³ ¸ðµåº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • Ŭ¶ó¿ìµå ±â¹Ý
  • ¿ÂÇÁ·¹¹Ì½º
  • À¥ ±â¹Ý

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • ¾à±¹
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • Becton, Dickinson and Company
  • Bluesight
  • Capsa Healthcare
  • eAgile Inc.
  • Epic Systems Corporation
  • GE HealthCare Technologies Inc.
  • GUARDIAN RFID
  • Impinj, Inc.
  • MCKESSON CORPORATION
  • Omnicell, Inc.
  • Oracle Corporation
  • RMS Omega
  • Swisslog Healthcare
  • Veradigm LLC
  • Yankee Alliance LLC.
LSH 24.10.28

The Global Medication Management Systems Market will exhibit a 9.8% CAGR from 2024 to 2032, driven by advancements in medical technology, a rising geriatric population, and the increasing prevalence of chronic diseases. Additionally, the growing adoption of electronic health records (EHRs) and e-prescribing further fuels this growth.

As chronic diseases like diabetes and hypertension become more prevalent, the demand for long-term medication therapy intensifies. Electronic prescribing (e-prescribing) and electronic health records (EHRs) play pivotal roles in propelling the medication management systems industry. These technologies ensure seamless medication information integration, enhancing communication among healthcare providers, pharmacies, and patients, and guaranteeing accurate and timely medication management.

The medication management systems market is categorized based on software type, deployment mode, end-use, and region.

The market categorizes software types into clinical decision support system solutions (CDSS), inventory management and supply chain management software, computerized physician order entry (CPOE), diversion medication management, administration software, assurance system software, and other software types. In 2023, the clinical decision support system solutions (CDSS) segment led the revenue generation with USD 1.1 billion. CDSS solutions aim to reduce medication errors by offering healthcare professionals real-time, evidence-based guidance during medication prescribing and dispensing. These systems can notify providers about potential drug interactions, allergies, and contraindications, thus averting harmful mistakes. Given the persistent concern of medication errors in healthcare, the rising adoption of CDSS in medication management underscores its growing importance.

The medication management systems market classifies deployment modes into cloud-based, on-premises, and web-based solutions. In 2023, the cloud-based segment led the market with a 48% share. Cloud-based medication management systems provide unmatched scalability. This allows healthcare providers, from small clinics to expansive hospital networks, to adjust their services based on demand without hefty upfront infrastructure investments. Such adaptability is a primary reason for the surge in cloud-based solution adoption.

Moreover, cloud-based systems negate the need for costly on-premises hardware, maintenance, and IT support, translating to substantial savings for healthcare providers. Organizations can transition to a subscription-based model, paying solely for the services they utilize, rather than investing in physical servers and software licenses. This financial advantage, especially appealing to smaller providers or those on tight budgets, is set to further propel the segment's growth in the market.

In 2023, North America medication management systems market accounted for a substantial USD 1.7 billion, with projections indicating a CAGR of 9.5% from 2024 to 2032. North America, and the U.S. in particular, boasts one of the globe's most sophisticated healthcare infrastructures. This advanced setup, coupled with a trend of early adoption of innovative solutions like medication management systems, underscores market growth. The region's high prevalence of chronic diseases, necessitating intricate medication regimens, further emphasizes the importance of these systems in ensuring adherence and minimizing medication errors.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising medication errors and need for patient safety
      • 3.2.1.2 Growing adoption of healthcare IT solutions
      • 3.2.1.3 Increasing hospital and pharmacy automation
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High implementation and maintenance costs
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Key market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Gap analysis
  • 3.10 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Software Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Clinical decision support system solutions (CDSS)
  • 5.3 Inventory management and supply chain management software
  • 5.4 Computerized physician order entry (CPOE)
  • 5.5 Diversion medication management
  • 5.6 Administration software
    • 5.6.1 Barcode medication administration record
    • 5.6.2 Electronic medication administration record
  • 5.7 Assurance system software
  • 5.8 Other software types

Chapter 6 Market Estimates and Forecast, By Deployment Mode, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cloud-based
  • 6.3 On-premise
  • 6.4 Web-based

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Pharmacies
  • 7.4 Ambulatory surgical centers
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Becton, Dickinson and Company
  • 9.2 Bluesight
  • 9.3 Capsa Healthcare
  • 9.4 eAgile Inc.
  • 9.5 Epic Systems Corporation
  • 9.6 GE HealthCare Technologies Inc.
  • 9.7 GUARDIAN RFID
  • 9.8 Impinj, Inc.
  • 9.9 MCKESSON CORPORATION
  • 9.10 Omnicell, Inc.
  • 9.11 Oracle Corporation
  • 9.12 RMS Omega
  • 9.13 Swisslog Healthcare
  • 9.14 Veradigm LLC
  • 9.15 Yankee Alliance LLC.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦